Your browser doesn't support javascript.
loading
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.
Gelderblom, Hans; Cropet, Claire; Chevreau, Christine; Boyle, Richard; Tattersall, Martin; Stacchiotti, Silvia; Italiano, Antoine; Piperno-Neumann, Sophie; Le Cesne, Axel; Ferraresi, Virginia; Penel, Nicolas; Duffaud, Florence; Cassier, Philippe; Toulmonde, Maud; Casali, Paolo; Taieb, Sophie; Guillemaut, Séverine; Metzger, Séverine; Pérol, David; Blay, Jean-Yves.
Affiliation
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, Netherlands.
  • Cropet C; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Chevreau C; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
  • Boyle R; Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Tattersall M; Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Stacchiotti S; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Italiano A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.
  • Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Ferraresi V; Regina Elena National Cancer Institute, Rome, Italy.
  • Penel N; Department of Medical Oncology, Centre Oscar Lambret, Université Lille 2, Lille, France.
  • Duffaud F; Hôpital de la Timone, Aix-Marseille Université, Marseille, France.
  • Cassier P; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Toulmonde M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Casali P; Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Taieb S; Medical Imaging Department, Centre Oscar Lambret, Université Lille 2, Lille, France.
  • Guillemaut S; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Metzger S; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Pérol D; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; University Claude Bernard Lyon 1, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.
Lancet Oncol ; 19(5): 639-648, 2018 05.
Article in En | MEDLINE | ID: mdl-29571946
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Synovitis, Pigmented Villonodular / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male Country/Region as subject: Europa / Oceania Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Synovitis, Pigmented Villonodular / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male Country/Region as subject: Europa / Oceania Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: Netherlands